// App-Quantinova.ai

1078 : Efficacy of mirtazapine in preventing delayed nausea and vomiting induced by highly emetogenic chemotherapy: An open-label, randomized, multicenter phase III trial.

Researchers

Presenter

  • Jun Cao

Principal Investigators

  • Biyun Wang

  • Zhonghua Wang

  • Jian Zhang

  • Leiping Wang

  • Enying Cao

  • Yannan Zhao

  • Zhe Feng

  • Quchang Ouyang

  • Shusen Wang

  • Xichun Hu

Medical Centers

  • Fudan University Shanghai Cancer Center, Shanghai, China

  • Hu Nan Tumor Hospital, Changsha, China

  • Cancer Hospital Zhongshan Medical, Guangzhou, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Mirtazapine

  • Aprepitant

  • Cisplatin

Outcome

  • N/A

Study Design

  • Randomized

  • Open Label

  • Multicenteric

Phase

  • III

Study Id's

  • NCT02336750

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved